2010Chinese Journal of Hospital PharmacyRequires access

Pharmacokinetics and bioequivalence of taurine granules in healthy volunteers

Zhiwen Jiang

Open publisher page 0 citations

Abstract

OBJECTIVE To investigate the pharmacokinetics and relative bioavailability of taurine granules in healthy volunteers and evaluate the bioequivalence.METHODS A single oral dose of 1.6 g taurine test and reference granules was given to 20 male healthy volunteers in a randomized,two-way crossover study.The concentration of taurine in serum was determined by high performance liquid chromatogram (HPLC)-fluorescence method.The pharmacokinetic parameters and relative bioavailability were calculated with DAS software to evaluate the bioequivalence of the two preparations.RESULTS The main pharmacokinetic parameters of test and reference preparations were as follows:t1/2(51.0±8.8) and (56.4±11.6)min;tmax (38.0±12.0) and (39.5±10.0)min;Cmax (54.0±8.4) and (54.9±9.5) mg·L-1;AUC0-360 min(5296.88±1123.50) and(5123.8±806.6)mg·min ·L-1;AUC(0-∞(5552.11±1149.57) and(5421.89±820.69)mg·min ·L-1,respectively.The differences of the major pharmacokinetic parameters between test and reference granules were not significant.The relative bioavailability of F was (105.0±26.3)%.CONCLUSION The statistical analysis of the results showed that the two preparations are bioequivalence.

About this research paper

What this paper is about

OBJECTIVE To investigate the pharmacokinetics and relative bioavailability of taurine granules in healthy volunteers and evaluate the bioequivalence.METHODS A single oral dose of 1.6 g taurine test and reference granules was given to 20 male healthy volunteers in a randomized,two-way crossover study.The concentration of taurine in serum was determined by high performance liquid chromatogram (HPLC)-fluorescence method.The pharmacokinetic parameters and relative bioavailability were calculated with DAS software to evaluate the bioequivalence of the two preparations.RESULTS The main pharmacokinetic parameters of test and reference preparations were as follows:t1/2(51.0±8.8) and (56.4±11.6)min;tmax (38.0±12.0) and (39.5±10.0)min;Cmax (54.0±8.4) and (54.9±9.5) mg·L-1;AUC0-360 min(5296.88±1123.50) and(5123.8±806.6)mg·min ·L-1;AUC(0-∞(5552.11±1149.57) and(5421.89±820.69)mg·min ·L-1,respectively.The differences of the major pharmacokinetic parameters between test and reference granules were not significant.The relative bioavailability of F was (105.0±26.3)%.CONCLUSION The statistical analysis of the results showed that the two preparations are bioequivalence.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To investigate the pharmacokinetics and relative bioavailability of taurine granules in healthy volunteers and evaluate the bioequivalence.METHODS A single oral dose of 1.6 g taurine test and reference granules was given to 20 male healthy volunteers in a randomized,two-way crossover study.The concentration of taurine in serum was determined by high performance liquid chromatogram (HPLC)-fluorescence method.The pharmacokinetic parameters and relative bioavailability were calculated with DAS software to evaluate the bioequivalence of the two preparations.RESULTS The main pharmacokinetic parameters of test and reference preparations were as follows:t1/2(51.0±8.8) and (56.4±11.6)min;tmax (38.0±12.0) and (39.5±10.0)min;Cmax (54.0±8.4) and (54.9±9.5) mg·L-1;AUC0-360 min(5296.88±1123.50) and(5123.8±806.6)mg·min ·L-1;AUC(0-∞(5552.11±1149.57) and(5421.89±820.69)mg·min ·L-1,respectively.The differences of the major pharmacokinetic parameters between test and reference granules were not significant.The relative bioavailability of F was (105.0±26.3)%.CONCLUSION The statistical analysis of the results showed that the two preparations are bioequivalence.

Key concepts: Bioequivalence, Bioavailability, Pharmacokinetics, Cmax, Crossover study, Pharmacology, Taurine, High-performance liquid chromatography

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics and bioequivalence of taurine granules in healthy volunteers — Research Paper | ScholarLens